Current Industrial ReportsU.S. Department of CommerceEconomics and Statistics AdministrationBureau of the Census
Pharmaceuticals, Except Biologicals - 1997
Information about the scope of the survey, methodology, explanation of terms,and historical notes for this survey may be found in the 1996 ManufacturingProfiles issued July 1998.
Obtaining reports: Current data are released electronically on Internet for all individual surveys as they become available. Use http://www.census.gov. econ/www/manumenu.html. Individual reports can be accessed by choosing "Current Industrial Reports (CIR's)," clicking on "Report Number Index;" from the "Industrial Products by Numeric Index," choose the survey of interest. Follow the menu to view the text (ASCII) file or PDF file or to download the worksheet file (WK format) to your personal computer.
These data are also available through the U.S. Department of Commerce and STAT-USA Electronic Bulletin Board by subscription. To access, dial 202-482-3870and follow the prompts to register. Also, you may call 202-482-1986 or 1-800-STAT-USA,for further information. The Internet address is: stat-usa.gov/.
For mail or fax copies of the publication, contact the Manufacturing and Construction Division information Center, 301-457-4673.
Address inquiries concerning these data to U.S. Department of Commerce, Bureau of the Census, Manufacturing and Construction Division, Washington, D.C. 20233, or callWalter R. Hunter, Jr., 301-457-4798.
Table 1. Value of Product Class Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 to 1987 [In millions of dollars]
Pharmaceutical preparations affecting neoplasms, endocrine system, and metabolic diseases, for human use.
Pharmaceutical preparations acting on the central nervous system and sense organs, for human use.
Pharmaceutical preparations acting on the cardiovascular system, for human use.
Pharmaceutical preparations acting on the respiratory system, for human use.
Pharmaceutical preparations acting on the digestive or genito-urinary system, for human use.
Pharmaceutical preparations acting on the skin for human use.
Vitamin, nutrient, and hematinic preparations, for human use.
Pharmaceutical preparations affecting parasitic and infective diseases, for human use.
Pharmaceutical preparations for veterinary use.
Pharmaceutical preparations affecting neoplasms, endocrine system, and metabolic diseases, for human use.
Pharmaceutical preparations acting on the central nervous system and sense organs, for human use.
Pharmaceutical preparations acting on the cardiovascular system, for human use.
Pharmaceutical preparations acting on the respiratory system, for human use.
Pharmaceutical preparations acting on the digestive or genito-urinary system, for human use.
Pharmaceutical preparations acting on the skin for human use.
Vitamin, nutrient, and hematinic preparations, for human use.
Pharmaceutical preparations affecting parasitic and infective diseases, for human use.
Pharmaceutical preparations for veterinary use.
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
Pharmaceutical preparations affecting neoplasms, endocrine system, and metabolic diseases, for human use.
Local and topical including anti-infective combinations.
Progestogens, excluding premenstrual tension preparations, see code 28345 85.
Sex hormone combinations, (except progestogen combinations).
Thyroid and antithyroid preparations, including
Radioactive isotopes for internal use.
neoplasms, the endocrine system, and metabolic for human use.
Pharmaceutical preparations acting on the central nervous system and the sense organs, for human use.
Parasympathomimetic cholinergic drugs.
Internal analgesics and antipyretics: Narcotic:
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
Other salicylates, such as sodium salicylate 2/.
Other internal analgesics and antipyretics, includ- ing effervescent types and suppositories 2/.
Anticonvulsants (except phenobarbital).
Central nervous system stimu- lants (respiratory and cere- bral stimulants, including sympathomimetic agents em- ployed mainly as CNS stimu- lants, excluding nondrug dietaries for weight control):
Anorexiants (except am- phetamines).
tract anesthetics and skin preparations used as anti- pruritics):
Eye and ear preparations, excluding anti-infectives, corticoids and antibacter- ials and antiseptics:
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
Other pharmaceutical prepara- tions acting on the central
nervous system and the sense organs for human use.
acting on the cardiovascular system, for human use.
Anti-arrythmics, such as propanolol and quinidine.
Calcium channel blockers such as isoptin, calan, procardia, cardizem, adalat.
Ace inhibitors, such as vasotec, capoten, prinivil, and zestril.
Other pharmaceutical prep- arations, acting on the cardiovascular system
including vasopressors, and antiheparin agents for, human use.
Pharmaceutical preparations acting on the respiratory system, for human use.
Antihistamines (except cold preparations and antiemetics).
Bronchial dilators, includ- ing anti-asthmatics.
Cough and cold preparations (prescription) : Cough preparations and expectorants (contain-
ing antitussive or other ingredients intended primarily to treat cough only):
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
Cold preparations (con- taining combinations of the following ingredi-
ents, (but not antitus- sive) nasal deconges- tant, antihistamine, analgesic, bioflava- noid, or antibiotic):
Other prescription cold preparations.
Cough and cold combina- tions (prescription).
Cough and cold preparations (nonprescription): Decongestants:
Other nonprescription cough and cold preparations.
Beta agonists such as proventil and ventolin.
Other pharmaceutical prep- arations acting on the respiratory system, for for human use.
Pharmaceutical preparations acting on the digestive or the genito-urinary systems, for human use.
Antacids, including acid neutralizing products with coating functions, but excluding efferves- cent salicylate prod- ucts classified as analgesics.
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
Bile therapy preparations, including bile products,
Antinauseants and motion sickness remedies (an- tiemetics), including antihistaminic anti- emetic preparations.
Lipotropics and choles- terol reducers.
Diet aids containing local anesthetics such as benzocaine.
H2 Blocking agents such as zantec, tagemet, carafate and pepcid.
Other antispasmodics and anticholiner- gics.
Urinary antibacterials and antiseptics.
Diuretics (excluding aminophylline, xan- thine, and rauwolfia- diuretic combinations. See cardiovascular preparations):
Contraceptive agents (except oral contracep- tives) aerosols, jels, sponges, and creams.
Premenstrual tension prep- arations.
Other pharmaceutical prep- arations acting on the genito-urinary system,
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
including urinary tract anesthetics, for human use.
Pharmaceutical preparations acting on the skin, for human use.
Emollients and protec- tives, including burn remedies and oint- ment bases.
Antipruritics and local anesthetic skin preparations.
Coal tar, sulfur and re- sorcinol preparations.
Antidandruff and anti- seborrheic prepara- tions (except dan- druff shampoos).
External analgesics and counterirritants:
Ointments, jellies, pastes, creams, ce- rates, and salves.
Liquid, (excluding rubbing alcohol but including liniments.
Other external analgesics and counterirritants.
Other pharmaceutical prep- arations acting on the skin, for human use.
Vitamin, nutrient, and hematinic preparations, for human use.
Multivitamins, plain and with minerals, (except B complex vitamins and fish liver oils).
Pediatric vitamin prep- arations (drops, suspensions and chewable tablets).
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
Nutrients, excluding thera- peutic dietary foods and infant formulas.
Hospital solutions, in- cluding dextran, etc., but excluding biologicals such as blood plasma.
Other vitamin, nutrient, and hematinic prepara- tions, for human use.
affecting parasitic and infec- tive diseases, for human use.
cluding cortcoid-anti-infec- tive combinations (see
Systemic antibiotic prep- arations: Broad and medium spec- trum (single or in combi- nations with other anti- biotics):
Tetracyclines, includ- ing chlortetracy- cline and congeners.
Cephalosporins, such as cefamandole nafate and cephalexin.
Erythromycins, such as erythromycin ethylsuc- cinate and erythromy- cin stearate.
Penicillins (single): Semisynthetic peni- cillins, such as amox- icillins, and ampicillin:
Other penicillins (ex- cept semisynthetic), such as penicillin V and penicillin G:
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
Other broad and medium spectrum antibiotics (except sulfa-antibio- tic combinations).
Antibiotics in combina- tion with sulfonamides.
Other systemic antibiotic preparations, including narrow-spectrum anti- biotics and streptomy- cins.
Isoniazid (isonicotinic acid hydrazide) prep- arations.
Sulfonamides (except anti- biotic sulfonamide combi- nations).
Antivirals, systemic, such as zovirax, and retrovir.
Other pharmaceutical prep- arations affecting parasitic and infective diseases, for human use.
Pharmaceutical preparations for veterinary use.
Antiseptics, wound dress- ings and fungicides.
ACTH (corticotropin) prep- arations.
Intravenous solutions and electrolytes.
Table 2. Value of Shipments of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996[In thousands of dollars]
Other pharmaceutical prep- arations for veterinary use.
- Represents zero. D Withheld to avoid disclosing data for individual companies. r/Revised 5 percent by 5 percent or more from previously published data X Not applicable.
1/Data for "bulk shipments" (column 4) are excluded from all horizontal seven-digit product detail totals; however, these data are included in all five-digit product class and four-digit industry level totals. Since bulk shipments are typically reported by a small number of producers, and often must be suppressed, inclusion of bulk shipments in all horizontal totals would require the suppression of additional detail. 2/Code 28342 24 combined with code 28342 28. 3/Code 28349 31 combined with code 28349 33.
Note: The percent of estimation for each item is indicated as follows: a/20 percent or more of this item is estimated.
Table 3. Domestic Value of Shipments, Exports, Imports, and Apparent Consumption of Pharmaceutical Preparations, Except Biologicals: 1997 and 1996 [Thousands of dollars]
Pharmaceutical preparations affecting neoplasms, endocrine system and metabolic diseases, for human use.
Pharmaceutical preparations acting on the central nervous system and sense organs, for human use.
Pharmaceutical preparations acting on the
Pharmaceutical preparations acting on the
Pharmaceutical preparations acting on the
digestive or genito-urinary system, for human use.
Pharmaceutical preparations acting on the skin, for human use.
Vitamin, nutrient, and hematinic preparations, for human use.
Pharmaceutical preparations affecting parasitic
Pharmaceutical preparations for veterinary use.
Pharmaceutical preparations affecting neoplasms, endocrine system and metabolic diseases, for human use.
Pharmaceutical preparations acting on the central nervous system and sense organs, for human use.
Pharmaceutical preparations acting on the
Pharmaceutical preparations acting on the
Pharmaceutical preparations acting on the digestive or genito-urinary system, for human use.
Pharmaceutical preparations acting on the skin, for human use.
Vitamin, nutrient, and hematinic preparations, for human use.
Pharmaceutical preparations affecting parasitic and infective diseases, for human use.
Pharmaceutical preparations for veterinary use.
1/Source: Bureau of the Census report EM 545, U.S. Exports. 2/Source: Bureau of the Census report IM 145, U.S. Imports for Consumption. 3/Apparent consumption represents new domestic supply and is derived by substracting exports from the total of manufacturers' shipments plus imports.
Saratoga: The Ultimate Racing Experience, Frank R. Scatoni, DAILY RACING FORM Incorporated, 2004,0972640169, 9780972640169, 144 pages. In a town that lives and breathes Thoroughbred racing, this titlebrings to life the total Saratoga racing experience. From the backside, frontside, cultural monuments, andafter- race-day social gatherings, racing aficionados will treasure this unique keepsake. G
Bromelain: A Literature Review and Discussion of its Therapeutic Applications Gregory S. Kelly, N.D. Abstract First introduced as a therapeutic compound in 1957, bromelain’s actions include:(1) inhibition of platelet aggregation; (2) fibrinolytic activity; (3) anti-inflammatory action;(4) anti-tumor action; (5) modulation of cytokines and immunity; (6) skin debridementproperties; (7) en